Cargando…
Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth
The neurotrophin-3 (NT-3) receptor tropomyosin receptor kinase C (TrkC/NTRK3) has been described as a dependence receptor and, as such, triggers apoptosis in the absence of its ligand NT-3. This proapoptotic activity has been proposed to confer a tumor suppressor activity to this classic tyrosine ki...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965893/ https://www.ncbi.nlm.nih.gov/pubmed/29750782 http://dx.doi.org/10.1371/journal.pbio.2002912 |
_version_ | 1783325394733105152 |
---|---|
author | Ménard, Marie Costechareyre, Clélia Ichim, Gabriel Blachier, Jonathan Neves, David Jarrosson-Wuilleme, Loraine Depping, Reinhard Koster, Jan Saintigny, Pierre Mehlen, Patrick Tauszig-Delamasure, Servane |
author_facet | Ménard, Marie Costechareyre, Clélia Ichim, Gabriel Blachier, Jonathan Neves, David Jarrosson-Wuilleme, Loraine Depping, Reinhard Koster, Jan Saintigny, Pierre Mehlen, Patrick Tauszig-Delamasure, Servane |
author_sort | Ménard, Marie |
collection | PubMed |
description | The neurotrophin-3 (NT-3) receptor tropomyosin receptor kinase C (TrkC/NTRK3) has been described as a dependence receptor and, as such, triggers apoptosis in the absence of its ligand NT-3. This proapoptotic activity has been proposed to confer a tumor suppressor activity to this classic tyrosine kinase receptor (RTK). By investigating interacting partners that might facilitate TrkC-induced cell death, we have identified the basic helix-loop-helix (bHLH) transcription factor Hey1 and importin-α3 (karyopherin alpha 4 [KPNA4]) as direct interactors of TrkC intracellular domain, and we show that Hey1 is required for TrkC-induced apoptosis. We propose here that the cleaved proapoptotic portion of TrkC intracellular domain (called TrkC killer-fragment [TrkC-KF]) is translocated to the nucleus by importins and interacts there with Hey1. We also demonstrate that Hey1 and TrkC-KF transcriptionally silence mouse double minute 2 homolog (MDM2), thus contributing to p53 stabilization. p53 transcriptionally regulates the expression of TrkC-KF cytoplasmic and mitochondrial interactors cofactor of breast cancer 1 (COBRA1) and B cell lymphoma 2–associated X (BAX), which will subsequently trigger the intrinsic pathway of apoptosis. Of interest, TrkC was proposed to constrain tumor progression in neuroblastoma (NB), and we demonstrate in an avian model that TrkC tumor suppressor activity requires Hey1 and p53. |
format | Online Article Text |
id | pubmed-5965893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-59658932018-06-02 Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth Ménard, Marie Costechareyre, Clélia Ichim, Gabriel Blachier, Jonathan Neves, David Jarrosson-Wuilleme, Loraine Depping, Reinhard Koster, Jan Saintigny, Pierre Mehlen, Patrick Tauszig-Delamasure, Servane PLoS Biol Research Article The neurotrophin-3 (NT-3) receptor tropomyosin receptor kinase C (TrkC/NTRK3) has been described as a dependence receptor and, as such, triggers apoptosis in the absence of its ligand NT-3. This proapoptotic activity has been proposed to confer a tumor suppressor activity to this classic tyrosine kinase receptor (RTK). By investigating interacting partners that might facilitate TrkC-induced cell death, we have identified the basic helix-loop-helix (bHLH) transcription factor Hey1 and importin-α3 (karyopherin alpha 4 [KPNA4]) as direct interactors of TrkC intracellular domain, and we show that Hey1 is required for TrkC-induced apoptosis. We propose here that the cleaved proapoptotic portion of TrkC intracellular domain (called TrkC killer-fragment [TrkC-KF]) is translocated to the nucleus by importins and interacts there with Hey1. We also demonstrate that Hey1 and TrkC-KF transcriptionally silence mouse double minute 2 homolog (MDM2), thus contributing to p53 stabilization. p53 transcriptionally regulates the expression of TrkC-KF cytoplasmic and mitochondrial interactors cofactor of breast cancer 1 (COBRA1) and B cell lymphoma 2–associated X (BAX), which will subsequently trigger the intrinsic pathway of apoptosis. Of interest, TrkC was proposed to constrain tumor progression in neuroblastoma (NB), and we demonstrate in an avian model that TrkC tumor suppressor activity requires Hey1 and p53. Public Library of Science 2018-05-11 /pmc/articles/PMC5965893/ /pubmed/29750782 http://dx.doi.org/10.1371/journal.pbio.2002912 Text en © 2018 Ménard et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ménard, Marie Costechareyre, Clélia Ichim, Gabriel Blachier, Jonathan Neves, David Jarrosson-Wuilleme, Loraine Depping, Reinhard Koster, Jan Saintigny, Pierre Mehlen, Patrick Tauszig-Delamasure, Servane Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth |
title | Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth |
title_full | Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth |
title_fullStr | Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth |
title_full_unstemmed | Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth |
title_short | Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth |
title_sort | hey1- and p53-dependent trkc proapoptotic activity controls neuroblastoma growth |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5965893/ https://www.ncbi.nlm.nih.gov/pubmed/29750782 http://dx.doi.org/10.1371/journal.pbio.2002912 |
work_keys_str_mv | AT menardmarie hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT costechareyreclelia hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT ichimgabriel hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT blachierjonathan hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT nevesdavid hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT jarrossonwuillemeloraine hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT deppingreinhard hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT kosterjan hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT saintignypierre hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT mehlenpatrick hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth AT tauszigdelamasureservane hey1andp53dependenttrkcproapoptoticactivitycontrolsneuroblastomagrowth |